As of November 2024, Theravance Biopharma has a market cap of $411.83M. This makes Theravance Biopharma the world's 12593th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $430.13M | -23.15% |
2023 | $559.73M | 0.18% |
2022 | $558.73M | 1.54% |
2021 | $550.27M | -37.82% |
2020 | $884.91M | -31.36% |
2019 | $1.29B | 1.17% |
2018 | $1.27B | -8.25% |
2017 | $1.39B | -12.52% |
2016 | $1.59B | 94.51% |
2015 | $816.19M | 9.85% |
2014 | $742.98M | - |